Nandrolone decanoate relieves joint pain in hypogonadal men: a novel prospective pilot study and review of the literature
- PMID: 32257859
- PMCID: PMC7108994
- DOI: 10.21037/tau.2019.11.03
Nandrolone decanoate relieves joint pain in hypogonadal men: a novel prospective pilot study and review of the literature
Abstract
Testosterone is an archetypal androgenic-anabolic steroid (AAS), while its exogenous administration is considered to be the gold standard for the treatment of male hypogonadism. The benefits are not due to its intrinsic nature alone but are due to the result of its interactions with the androgen receptor (AR). As the management of hypogonadism continues to advance into the modern era, it would be preferable for modern andrologists to have multiple tools at their disposal to influence AR activity. Nandrolone, or 19-nortestosterone, is one such compound. In the following review of the literature, we examine the history, pharmacology, and clinical applications of this medication. We also present the results of our novel pilot study examining the favorable effects of nandrolone on joint pain for hypogonadal men.
Keywords: Nandrolone; andrology; arthritis; hypogonadism; joint pain; testosterone; testosterone deficiency.
2020 Translational Andrology and Urology. All rights reserved.
Conflict of interest statement
Conflicts of Interest: The focused issue “Contemporary Issues and Controversies in Men’s Health” was commissioned by the editorial office without any funding or sponsorship. LIL serves as an unpaid editorial board member of Translational Andrology and Urology from Nov 2019 to Oct 2021 and served as the unpaid Guest Editor of the focused issue. Dr. Kovac: Abbvie (Consultant). Dr. Lipshultz: American Medical Systems (Speaker); AbbVie (Consultant); Lipocine (Consultant); Aytu Bioscience (Consultant); Endo Pharmaceuticals (Speaker/Consultant). The other authors have no conflicts of interest to declare.
Figures
Similar articles
-
Novel Uses for the Anabolic Androgenic Steroids Nandrolone and Oxandrolone in the Management of Male Health.Curr Urol Rep. 2016 Oct;17(10):72. doi: 10.1007/s11934-016-0629-8. Curr Urol Rep. 2016. PMID: 27535042 Review.
-
Beyond testosterone cypionate: evidence behind the use of nandrolone in male health and wellness.Transl Androl Urol. 2016 Apr;5(2):213-9. doi: 10.21037/tau.2016.03.03. Transl Androl Urol. 2016. PMID: 27141449 Free PMC article. Review.
-
Effects of nandrolone decanoate therapy in borderline hypogonadal men with HIV-associated weight loss.J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Feb 1;20(2):137-46. doi: 10.1097/00042560-199902010-00005. J Acquir Immune Defic Syndr Hum Retrovirol. 1999. PMID: 10048900 Clinical Trial.
-
Delta-4-androstene-3,17-dione binds androgen receptor, promotes myogenesis in vitro, and increases serum testosterone levels, fat-free mass, and muscle strength in hypogonadal men.J Clin Endocrinol Metab. 2005 Feb;90(2):855-63. doi: 10.1210/jc.2004-1577. Epub 2004 Nov 2. J Clin Endocrinol Metab. 2005. PMID: 15522925
-
Cytoarchitecture of steroid dependent target tissues after testosterone administration compared to nandrolone decanoate in castrated rats in the aim of Hershberger bio test.Rom J Morphol Embryol. 2014;55(3 Suppl):1143-8. Rom J Morphol Embryol. 2014. PMID: 25607397
References
-
- Dohle GR, Arver S, Bettocchi C, et al. EAU guidelines on male hypogonadism. 2016. Available online: https://uroweb.org/wp-content/uploads/EAU-Guidelines-Male-Hypogonadism-2...
-
- Srinivas-Shankar U, Roberts SA, Connolly MJ, et al. Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab 2010;95:639-50. 10.1210/jc.2009-1251 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials